KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Depreciation & Amortization (CF): 2009-2025

Historic Depreciation & Amortization (CF) for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $306.0 million.

  • Bausch Health Companies' Depreciation & Amortization (CF) fell 4.97% to $306.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 4.97%. This contributed to the annual value of $1.3 billion for FY2024, which is 0.24% up from last year.
  • As of Q3 2025, Bausch Health Companies' Depreciation & Amortization (CF) stood at $306.0 million, which was down 0.33% from $307.0 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year Depreciation & Amortization (CF) high stood at $404.0 million for Q2 2021, and its period low was $301.0 million during Q3 2023.
  • For the 3-year period, Bausch Health Companies' Depreciation & Amortization (CF) averaged around $313.5 million, with its median value being $315.0 million (2023).
  • Per our database at Business Quant, Bausch Health Companies' Depreciation & Amortization (CF) fell by 16.22% in 2021 and then grew by 6.98% in 2024.
  • Over the past 5 years, Bausch Health Companies' Depreciation & Amortization (CF) (Quarterly) stood at $363.0 million in 2021, then decreased by 0.83% to $360.0 million in 2022, then dropped by 8.61% to $329.0 million in 2023, then fell by 6.69% to $307.0 million in 2024, then declined by 4.97% to $306.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $306.0 million for Q3 2025, versus $307.0 million for Q2 2025 and $305.0 million for Q1 2025.